Sarepta Therapeutics, Inc. (SRPT) Return on equity 2016–2025
Sarepta Therapeutics, Inc. (SRPT) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-62.5%FY2025 · since FY2016: -79.4% → -62.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -62.5% | -77.9 pp |
| FY2024 | 15.4% | +77.8 pp |
| FY2023 | -62.4% | +120.4 pp |
| FY2022 | -182.7% | -137.6 pp |
| FY2021 | -45.1% | +27.6 pp |
| FY2020 | -72.7% | +14.7 pp |
| FY2019 | -87.4% | -52.3 pp |
| FY2018 | -35.1% | -28.6 pp |
| FY2017 | -6.4% | +73.0 pp |
| FY2016 | -79.4% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice